AI Science Tracker

OpenCRISPR-1: a genome editor designed by language models

Profluent · 22 Apr 2024 · biology

Discovery

Profluent

OpenCRISPR-1: a genome editor designed by language models

Profluent built an atlas of 5.1 million CRISPR-Cas proteins and generated a Cas9-like editor with 403 mutations relative to SpCas9. Of 48 generated sequences, the best (OpenCRISPR-1) achieved 55.7% on-target editing versus 48.3% for SpCas9, and 0.32% off-target editing versus 6.1%. Human cells in the laboratory only; company data; the page does not indicate peer review.

Technology: Protein language models

Family OpenCRISPR: profile · models page

Publication: Publication status unspecified in annotation · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Not reported
  • Test type: direct test
  • Tested: Of 48 selected generated sequences, the best (OpenCRISPR-1) was tested in human cells: 55.7% on-target editing vs 48.3% for SpCas9, and 0.32% off-target vs 6.1%.
  • Still unknown: The company article has no explicit limitations section and does not state whether a preprint or peer review exists.
  • AI role: A language model pretrained on protein data and steered to CRISPR families using a 5.1-million-protein atlas generated Cas9-like nucleases and compatible sgRNAs.

Evidence sources: https://www.profluent.bio/media/editing-the-human-genome-with-ai

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 5/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.